BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20205099)

  • 21. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter.
    Wesche MF; Tiel-V Buul MM; Lips P; Smits NJ; Wiersinga WM
    J Clin Endocrinol Metab; 2001 Mar; 86(3):998-1005. PubMed ID: 11238476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone density and metabolism in subjects with microdeletion of chromosome 22q11 (del22q11).
    Stagi S; Lapi E; Gambineri E; Manoni C; Genuardi M; Colarusso G; Conti C; Chiarelli F; de Martino M; Azzari C
    Eur J Endocrinol; 2010 Aug; 163(2):329-37. PubMed ID: 20516202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
    Elmaataoui A; Elmachtani Idrissi S; Dami A; Bouhsain S; Chabraoui L; Ouzzif Z
    Pathol Biol (Paris); 2014 Feb; 62(1):49-54. PubMed ID: 24461391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractional calcium absorption is increased in girls with Rett syndrome.
    Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone density and mineral metabolism in thyroidectomized patients treated with long-term L-thyroxine.
    Giannini S; Nobile M; Sartori L; Binotto P; Ciuffreda M; Gemo G; Pelizzo MR; D'Angelo A; Crepaldi G
    Clin Sci (Lond); 1994 Nov; 87(5):593-7. PubMed ID: 7874849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
    Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
    Thyroid; 1996 Jun; 6(3):169-75. PubMed ID: 8837322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
    La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
    Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal and biochemical parameters correlated with bone densitometric markers in prepubertal Hungarian children.
    Csakvary V; Puskas T; Oroszlan G; Lakatos P; Kalman B; Kovacs GL; Toldy E
    Bone; 2013 May; 54(1):106-12. PubMed ID: 23385479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
    Panico A; Lupoli GA; Fonderico F; Marciello F; Martinelli A; Assante R; Lupoli G
    Thyroid; 2009 May; 19(5):437-42. PubMed ID: 19415993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of bone mineral density and bone metabolism in children with multiple bone fractures.
    Michałus I; Chlebna-Sokół D; Rusińska A; Jakubowska-Pietkiewicz E; Kulińska-Szukalska K
    Ortop Traumatol Rehabil; 2008; 10(6):602-12. PubMed ID: 19153549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women.
    Riggs BL; O'Fallon WM; Muhs J; O'Connor MK; Kumar R; Melton LJ
    J Bone Miner Res; 1998 Feb; 13(2):168-74. PubMed ID: 9495509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and side effects of the treatment of euthyroid goiter with levo-thyroxine or triiodothyroacetic acid.
    Brenta G; Schnitman M; Fretes O; Facco E; Gurfinkel M; Damilano S; Pacenza N; Blanco A; Gonzalez E; Pisarev MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5287-92. PubMed ID: 14602763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.
    Terzi R; Dindar S; Terzi H; Demirtaş Ö
    Metab Syndr Relat Disord; 2015 Mar; 13(2):78-83. PubMed ID: 25470355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.